These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2110079)

  • 1. Changes in gonadotropin and alpha-subunit secretion after a single administration of gonadotropin-releasing hormone antagonist in adult males.
    Lahlou N; Delivet S; Bardin CW; Roger M; Spitz IM; Bouchard P
    Fertil Steril; 1990 May; 53(5):898-905. PubMed ID: 2110079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of concordant luteinizing hormone (LH), testosterone, and alpha-subunit pulses after LH-releasing hormone antagonist administration in normal men.
    Pavlou SN; Veldhuis JD; Lindner J; Souza KH; Urban RJ; Rivier JE; Vale WW; Stallard DJ
    J Clin Endocrinol Metab; 1990 May; 70(5):1472-8. PubMed ID: 2110578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
    Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS
    J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the suppressive effects of testosterone and a potent new gonadotropin-releasing hormone antagonist on gonadotropin and inhibin levels in normal men.
    Bagatell CJ; McLachlan RI; de Kretser DM; Burger HG; Vale WW; Rivier JE; Bremner WJ
    J Clin Endocrinol Metab; 1989 Jul; 69(1):43-8. PubMed ID: 2499592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men.
    Pavlou SN; Wakefield G; Schlechter NL; Lindner J; Souza KH; Kamilaris TC; Konidaris S; Rivier JE; Vale WW; Toglia M
    J Clin Endocrinol Metab; 1989 Feb; 68(2):446-54. PubMed ID: 2537334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of decreasing the frequency of gonadotropin-releasing hormone stimulation on gonadotropin secretion in gonadotropin-releasing hormone-deficient men and perifused rat pituitary cells.
    Finkelstein JS; Badger TM; O'Dea LS; Spratt DI; Crowley WF
    J Clin Invest; 1988 Jun; 81(6):1725-33. PubMed ID: 3290251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of luteinizing hormone, follicle-stimulating hormone, and free alpha-subunit secretion from the gonadotrope by gonadotropin-releasing hormone (GnRH): evidence from the use of two GnRH antagonists.
    Hall JE; Whitcomb RW; Rivier JE; Vale WW; Crowley WF
    J Clin Endocrinol Metab; 1990 Feb; 70(2):328-35. PubMed ID: 2105329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulsatile gonadotropin secretion after discontinuation of long term gonadotropin-releasing hormone (GnRH) administration in a subset of GnRH-deficient men.
    Finkelstein JS; Spratt DI; O'Dea LS; Whitcomb RW; Klibanski A; Schoenfeld DA; Crowley WF
    J Clin Endocrinol Metab; 1989 Aug; 69(2):377-85. PubMed ID: 2502554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of administration of a gonadotropin-releasing hormone (GnRH) antagonist (Nal-Glu) during the periovulatory period: the luteinizing hormone surge requires secretion of GnRH.
    Dubourdieu S; Charbonnel B; D'Acremont MF; Carreau S; Spitz IM; Bouchard P
    J Clin Endocrinol Metab; 1994 Feb; 78(2):343-7. PubMed ID: 8106622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marked suppression of gonadotropins and testosterone by an antagonist analog of gonadotropin-releasing hormone in men.
    Salameh W; Bhasin S; Steiner B; McAdams LA; Peterson M; Swerdloff R
    Fertil Steril; 1991 Jan; 55(1):156-64. PubMed ID: 1898888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of pituitary glycoprotein alpha-subunit secretion after administration of a luteinizing hormone-releasing hormone antagonist in normal men.
    Lindner J; Rivier JE; Vale WW; Pavlou SN
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1219-24. PubMed ID: 1690747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of gonadotrophin releasing hormone antagonist and agonist on the pulsatile release of gonadotrophins and alpha-subunit in postmenopausal women.
    Couzinet B; Lahlou N; Thomas G; Thalabard JC; Bouchard P; Roger M; Schaison G
    Clin Endocrinol (Oxf); 1991 Jun; 34(6):477-83. PubMed ID: 1716186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concordant suppression of serum immunoreactive luteinizing hormone (LH), follicle-stimulating hormone, alpha subunit, bioactive LH, and testosterone in postmenopausal women by a potent gonadotropin releasing hormone antagonist (detirelix).
    Andreyko JL; Monroe SE; Marshall LA; Fluker MR; Nerenberg CA; Jaffe RB
    J Clin Endocrinol Metab; 1992 Feb; 74(2):399-405. PubMed ID: 1370507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differing responses of plasma bioactive and immunoreactive follicle-stimulating hormone and luteinizing hormone to gonadotropin-releasing hormone antagonist and agonist treatments in postmenopausal women.
    Matikainen T; Ding YQ; Vergara M; Huhtaniemi I; Couzinet B; Schaison G
    J Clin Endocrinol Metab; 1992 Sep; 75(3):820-5. PubMed ID: 1517372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose administration of the gonadotropin-releasing hormone antagonist, Nal-Lys (antide) to healthy men.
    Bagatell CJ; Conn PM; Bremner WJ
    Fertil Steril; 1993 Oct; 60(4):680-5. PubMed ID: 8405525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex steroid control of gonadotropin secretion in the human male. I. Effects of testosterone administration in normal and gonadotropin-releasing hormone-deficient men.
    Finkelstein JS; Whitcomb RW; O'Dea LS; Longcope C; Schoenfeld DA; Crowley WF
    J Clin Endocrinol Metab; 1991 Sep; 73(3):609-20. PubMed ID: 1908484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal effects of single gonadotropin-releasing hormone antagonist doses in men.
    Jockenhövel F; Bhasin S; Steiner BS; Rivier JE; Vale WW; Swerdloff RS
    J Clin Endocrinol Metab; 1988 May; 66(5):1065-70. PubMed ID: 3129447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of two different delivery systems on gonadotropin-releasing hormone (GnRH) antagonist-induced suppression of gonadotropins and testosterone in man.
    Salameh W; Bhasin S; Steiner BS; McAdams LA; Peterson M; Rivier JE; Vale WW; Swerdloff RS
    J Androl; 1994; 15(1):22-8. PubMed ID: 8188535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of increasing the frequency of low doses of gonadotropin-releasing hormone (GnRH) on gonadotropin secretion in GnRH-deficient men.
    Spratt DI; Finkelstein JS; Butler JP; Badger TM; Crowley WF
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1179-86. PubMed ID: 3106396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose effects of the gonadotropin-releasing hormone antagonist, Nal-Glu, combined with testosterone enanthate on gonadotropin levels in normal men.
    Bagatell CJ; Rivier JE; Bremner WJ
    Fertil Steril; 1995 Jul; 64(1):139-45. PubMed ID: 7789550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.